Sigma Healthcare exits PE-owned Boots acquisition talks
Australia’s Sigma Healthcare has withdrawn from the sale process for UK pharmacy chain and Sycamore Partners portfolio company Boots, stepping back from a potential transaction that was expected to value the business at up to $10bn, according to a report by Bloomberg.

